A controlled study of risk factors for disease and current problems in long-term testicular cancer survivors

Journal of Cancer Survivorship

Volumn 4, Issue 3, 2010, Pages 256-265

  Dahl, Christian Falk ^a   Haugnes, Hege Sagstuen ^b   Bremnes, Roy ^b   Dahl, Olav ^c   Fosså, Sophie D ^d,e   Klepp, Olbjørn ^f   Wist, Erik ^g   Dahl, Alv A ^d,e  

^a UPPSALA UNIVERSITY   (Sweden)

^b UNIVERSITY OF TROMSØ   (Norway)

^c HAUKELAND UNIVERSITY HOSPITAL   (Norway)

^d OSLO UNIVERSITY HOSPITAL   (Norway)

^e UNIVERSITY OF OSLO   (Norway)

^f NORWEGIAN UNIVERSITY OF SCIENCE AND TECHNOLOGY   (Norway)

^g ULLEVÅL UNIVERSITY HOSPITAL   (Norway)

Author keywords

Cancer survivor; Quality of life; Risk factor; Testicular cancer

Indexed keywords

ADOLESCENT; ADULT; AGED; ARTICLE; COMPARATIVE STUDY; CROSS-SECTIONAL STUDY; GENERAL ASPECTS OF DISEASE; HUMAN; MALE; MIDDLE AGED; ORCHIECTOMY; PSYCHOLOGICAL ASPECT; QUALITY OF LIFE; QUESTIONNAIRE; RISK FACTOR; SURVIVOR; TESTIS TUMOR;

ADOLESCENT; ADULT; AGED; CROSS-SECTIONAL STUDIES; DISEASE; HUMANS; MALE; MIDDLE AGED; ORCHIECTOMY; QUALITY OF LIFE; QUESTIONNAIRES; RISK FACTORS; SURVIVORS; TESTICULAR NEOPLASMS; YOUNG ADULT;

EID: 78649629242     PISSN: 19322259     EISSN: 19322267     Source Type: Journal    
DOI: 10.1007/s11764-010-0133-y     Document Type: Article

References (33)

1. Dahl AA, Haaland CF, Mykletun A, Bremnes R, Dahl O, Klepp O, et al. Study of anxiety disorder and depression in long-term survivors of testicular cancer. J Clin Oncol. 2005; 10: 2389-95.
2. Orre IJ, Fosså SD, Murison R, Dahl AA, Ueland T, Aukrust P, et al. Chronic fatigue in long-term survivors of testicular cancer. J Psychosom Res. 2008; 64: 363-71.
3. Skaali T, Fosså SD, Bremnes R, Dahl O, Haaland C, Rønneberg Hauge E, et al. Fear of recurrence in long-term testicular cancer survivors. Psycho-Oncol. 2009; 18: 580-8.
4. Oldenburg J, Fosså SD, Dahl AA. Scale for Chemotherapy-induced Long-term Neurotoxicity (SCIN): psychometrics, validation, and findings in a large sample of testicular cancer survivors. Qual Life Res. 2006; 15: 791-800.
5. Haugnes HS, Aass N, Fosså SD, Dahl O, Brydøy M, Aasebø U, et al. Pulmonary function in long-term survivors of testicular cancer. J Clin Oncol. 2009; 27: 2779-86.
6. Haugnes HS, Aass N, Fosså SD, Dahl O, Klepp O, Wist EA, et al. Predicted cardiovascular mortality and reported cardiovascular morbidity in testicular cancer survivors. J Cancer Surviv. 2008; 2: 128-37.
7. Haugnes HS, Aass N, Fosså SD, Dahl O, Klepp O, Wist EA, et al. Components of the metabolic syndrome in long-term survivors of testicular cancer. Ann Oncol. 2007; 18: 241-8.
8. Wethal T, Kjekshus J, Røislien J, Ueland T, Andreassen AK, Wergeland R, et al. Treatment-related differences in cardiovascular risk factors in long-term survivors of testicular cancer. J Cancer Surviv. 2007; 1: 8-16.
9. Orre IJ, Murison R, Dahl AA, Ueland T, Aukrust P, Fosså SD. Levels of circulating interleukin-1 receptor antagonist and C-reactive protein in long-term survivors of testicular cancer with chronic cancer-related fatigue. Brain Behav Immun. 2009; 23: 868-74.
10. Wallace RB. Maxcy-Rosenau-Last Public health and preventive medicine. 15th ed. New York: McGraw-Hill Medical; 2007.
11. Brisette I, Cohen S, Seeman TE. Measuring social integration and social networks. In: Cohen S, Underwood LG, Gottlieb BH, editors. Social support: measurement and intervention. Oxford: Oxford University Press; 2000. p. 53-85.
12. Meinardi MT, Gietema JA, van der Graaf WTA, van Veldhuisen DJ, Runne MA, Sluiter WJ, et al. Cardiovascular morbidity in long-term survivors of metastatic testicular cancer. J Clin Oncol. 2000; 18: 1725-32.
13. Holmen J, Midthjell K, Krüger Ø, Langhammer A, Holmen TL, Bratberg GH, et al. The Nord-Trøndelag Health Study 1995-97 (HUNT 2): objectives, contents, methods and participation. Nor Epidemiol. 2003; 13: 19-32.
14. Aasland OG, Amundsen A, Bovim G, Fauske S, Mørland J. Identification of patients at risk of alcohol related damage (in Norwegian). Tidsskr Nor Laegeforen. 1990; 110: 1523-7.
15. Aertgeerts B, Buntinx F, Kester A. The value of the CAGE in screening for alcohol abuse and alcohol dependence in general clinical populations: a diagnostic meta-analysis. J Clin Epidemiol. 2004; 57: 30-9.
16. Thorsen L, Nystad W, Stigum H, Dahl O, Klepp O, Bremnes RM, et al. The association between self-reported physical activity and prevalence of depression and anxiety in long-term survivors of testicular cancer and in general population sample. Support Care Cancer. 2005; 13: 637-46.
17. Conroy RM, Pyorla K, Fitzgerald AP, Sans S, Menotti A, De Backer G, et al. Estimation of ten-year risk of fatal cardiovascular disease in Europe: the SCORE project. Eur Heart J. 2003; 24: 987-1003.
18. Grov EK, Fosså SD, Bremnes R, Dahl O, Klepp O, Wist E, et al. Strong associations between long term morbidity and the personality trait of neuroticism in testicular cancer survivors. Acta Oncol. 2009; 48: 842-9.
19. Bjelland I, Dahl AA, Haug TT, Neckelmann D. The validity of The Hospital Anxiety and Depression Scale: an updated literature review. J Psychosom Res. 2002; 52: 69-77.
20. Rosenberg M. Society and the adolescent self-image. Princeton: Princeton University Press; 1965.
21. Tambs K. Moderate effects of hearing loss on mental health and subjective well-being: results from the Nord-Trøndelag Hearing Loss Study. Psychosom Med. 2004; 66: 776-82.
22. Dahl AA, Bremnes R, Dahl O, Klepp O, Wist E, Fosså SD. Is the sexual function compromised in long-term testicular cancer survivors? Eur Urol. 2007; 52: 1438-47.
23. Ware Jr JE, Snow KK, Kosinski M, Gandek B. SF-36® Health Survey: manual and interpretation guide. Lincoln: QualityMetric Inc; 2000.
24. Ware Jr JE, Gandek B, Kosinski M, Aaronson NK, Apolone G, Brazier J, et al. The equivalence of SF-36 health score estimates using standard and country-specific algorithms in 10 countries: results from the IQOLA Project. International Quality of Life Assessment. J Clin Epidemiol. 1998; 51: 1167-70.
25. Lipsey MW, Wilson DB. Practical meta-analysis. Thousand Oakes: SAGE; 2001.
26. Nakagawa S, Cuthill IC. Effect size, confidence interval and statistical significance: a practical guide for biologists. Biol Rev. 2007; 82: 591-605.
27. Cohen J. Statistical power analysis for the behavioral sciences. 2nd ed. Hillsdale: Earlbaum; 1988.
28. Deslandes A, Moraes H, Ferreira C, Veiga H, Silveira H, Mouta R, et al. Exercise and mental health: many reasons to move. Neuropsychobiol. 2009; 59: 191-8.
29. Park CL, Edmondson D, Fenster JR, Blank TO. Positive and negative health behavior changes in cancer survivors. A stress and coping perspective. J Health Psychol. 2008; 13: 198-206.
30. Cramp F, Danile J. Exercise for the management of cancer-related fatigue in adults. Cochrane Database Syst Rev. 2008; 16: CD006145.
31. Mykletun A, Dahl AA, Haaland CF, Bremnes R, Dahl O, Klepp O, et al. Side effects and cancer-related distress determine quality of life in long-term survivors of testicular cancer. J Clin Oncol. 2005; 23: 3061-8.
32. Fayers PM, Machin D. Quality of life: the assessment, analysis and interpretation of patient-reported outcomes. 2nd ed. Chicester: Wiley; 2007.
33. Mäntysekä P, Kumpusalo E, Ahonen R, Kumpusalo A, Kauhanen J, Viinimaki H, et al. Pain as a reason to visit the doctor: a study of Finnish primary health care. Pain. 2001; 89: 175-80.